Skip to content
Screener
Century Therapeutics logo

Century Therapeutics

IPSC

Century Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brent Pfeiffenberger, with a market cap of $387.5M.

Market cap
$387.5M+771%

We’re still putting together Century Therapeutics’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move Century Therapeutics up the queue, and we’ll analyze its filings next.

Earnings

Q2 2026 report

August 12, 2026

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.6M
EPS estimate-$0.12

Profile

Listed2021
Employees165.0
CEOBrent Pfeiffenberger
FilingsSEC EDGAR